GlassScriptPhysician profile
Orlando A Landrum
NPI 1932159910
$34,237.86
in general payments reported to CMS, 2019-2025
26 companies · $6,020 in 2025
The $6,020 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $110 · 2021: $9,612 · 2022: $16K · 2023: $963 · 2024: $1,355 · 2025: $6,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $6,122 · Food and Beverage: $1,502 · Travel and Lodging: $699 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $6,122.30 |
| Food and Beverage | $1,501.60 |
| Travel and Lodging | $698.63 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $17,661.91 | 2021-2022 | |
| Neuronetics, INC. | $11,896.66 | 2022-2025 | Neurostar Tms Therapy System |
| Acelrx Pharmaceuticals, INC. | $1,618.53 | 2021 | |
| Abbott Laboratories | $1,116.87 | 2020-2025 | Proclaim, Eterna |
| Genesys Orthopedics Systems, L.L.C. | $759.46 | 2023 | Sacroiliac Joint Fusion System |
| Boston Scientific Corporation | $323.10 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Nalu Medical, INC. | $210.65 | 2021-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $118.51 | 2019-2024 | Senza |
| Kerecis Limited | $99.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Collegium Pharmaceutical, INC. | $64.37 | 2019-2020 | |
| Stryker Corporation | $51.02 | 2023 | Spinejack |
| Spinal Simplicity, LLC | $40.14 | 2021-2024 | Ha Minuteman G3-R |
| Globus Medical, INC. | $35.40 | 2025 | Senza |
| Teva Pharmaceuticals USA, INC. | $26.90 | 2019 | |
| Scilex Pharmaceuticals INC. | $26.54 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $25.74 | 2023 | Painteq |
| Si-Bone, INC. | $23.09 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.30 | 2022 | |
| Brainsway USA INC | $19.61 | 2022 | |
| Vertos Medical, INC. | $16.66 | 2021 | |
| Sonex Health, INC. | $16.16 | 2021 | |
| Amgen INC. | $15.22 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.15 | 2019 | |
| Fidia Pharma USA INC. | $13.05 | 2022 | |
| Abbvie INC. | $12.68 | 2021 | |
| Biodelivery Sciences International, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orlando Landrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.